$PYPD
PolyPid Ltd.
Nasdaq · Healthcare · Surgical & Medical Instruments & Apparatus · Petach Tikva, Israel
PYPD chart
What traders are saying about $PYPD
Latest postsPolyPid Ltd. news
- PolyPid Ltd expected to post earnings of 6 cents a share - Earnings Preview
TradingView ·
- PolyPid Ltd. (PYPD) Seasonal returns chart
Yahoo Finance UK ·
- PolyPid (PYPD) Slips 2.58% to $5.67 as Shares Test Lower Support Zone - Gap and Go
www.dars.gov.et ·
- PYPD Q3'26 Earnings: revenue estimate is 30.00M USD
TradingView ·
- PolyPid Ltd. rated BUY with 35% upside ahead of 2026 FDA decision on infection-prevention drug D-PLEX100
Pluang ·
- PolyPid: Strong Phase 3 Data Support A Buy Ahead Of November's FDA Decision (NASDAQ:PYPD)
Seeking Alpha ·
- PolyPid to Report Third Quarter 2026 Financial Results and Operational Highlights on November 11, 2026
Yahoo Finance ·
- PolyPid Targets 2027 D-PLEX100 Launch, Unveils Diabetic Foot Infection Program
marketbeat.com ·
- PolyPid Unveils Expanded Pipeline Strategy, Introducing PD01B, a New Kynatrix™ Based Product Candidate for the Treatment of Diabetic Foot Infections
Yahoo Finance ·
- PolyPid to Present D-PLEX₁₀₀ Microbiology Data at IDWeek 2026
Yahoo Finance ·
- PolyPid to Host Virtual Investor Day on Wednesday, October 28, 2026
Yahoo Finance ·
- PolyPid Nears FDA Decision for D-PLEX100 After Strong Phase III Data
marketbeat.com ·
PolyPid Ltd. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$34.2M | -$29.0M | -$23.9M | -$39.6M |
| Diluted EPS | $2.09 | $4.91 | $16.93 | $61.09 |
| Total assets (year end) | $22.3M | $25.2M | $15.4M | $26.0M |
| Cash and equivalents (year end) | $6.4M | $15.6M | $5.3M | $8.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
About PolyPid Ltd.
- Ticker
- PYPD (Nasdaq)
- Industry
- Surgical & Medical Instruments & Apparatus
- Headquarters
- Petach Tikva, Israel
- Incorporated in
- Israel
- Fiscal year end
- December 31
- SEC CIK
- 1611842
Frequently asked questions
What exchange is PolyPid Ltd. listed on?
PolyPid Ltd. trades on the Nasdaq under the ticker symbol PYPD.
What industry is PolyPid Ltd. in?
PolyPid Ltd. is classified by the SEC under "Surgical & Medical Instruments & Apparatus", part of the Healthcare sector on StockTweeting.
Where is PolyPid Ltd. headquartered?
PolyPid Ltd.'s business address on file with the SEC is in Petach Tikva, Israel.
When does PolyPid Ltd.'s fiscal year end?
PolyPid Ltd.'s fiscal year ends on December 31.